First product, Profi™, is a new once-daily nasal spray based on novel science from Boston's Brigham and Women's Hospital and used proactively to support respiratory wellnessBOSTON and COLUMBUS, Ohio, Oct. 10, 2023 /PRNewswire/ -- Akita Biosciences, a biotechnology company focused on consumer health, is launching today with a mission to bring novel therapies to market.

第一产品，Profi™, 是一种新的每日一次的鼻腔喷雾剂，基于波士顿布莱根妇女医院的新科学，积极用于支持呼吸健康，俄亥俄州波士顿和哥伦布，2023年10月10日/PRNewswire/-Akita Biosciences，一家专注于消费者健康的生物技术公司，今天正在发射，其使命是将新疗法推向市场。

The company is developing pioneering science around the importance of the nasal cavity, both as a pathway for therapeutics and as a way to defend against illness. Akita Biosciences was founded based on research conducted at Brigham and Women's Hospital in Boston..

该公司正在围绕鼻腔的重要性开发开创性科学，既可作为治疗途径，也可作为防御疾病的途径。秋田生物科学公司成立于波士顿布莱根妇女医院的研究。。

Continue Reading

继续阅读

Profi helps block and remove airborne contaminants for up to 8 hours.

Profi帮助阻止和清除空气污染物长达8个小时。

Everyday nasal spray is great for travel, groups, and work.

日常鼻腔喷雾剂非常适合旅行，群体和工作。

'The nasal passage is the primary entry point for many respiratory pathogens, and research suggests it may be an overlooked avenue for defending against infections,' said Dr. Jeff Karp, a co-founder of Akita Biosciences and also a Professor at Brigham and Women's Hospital, Harvard Medical School.

秋田生物科学联合创始人兼布莱根妇女教授杰夫·卡普博士说：“鼻通道是许多呼吸道病原体的主要切入点，研究表明它可能是一种被忽视的防御感染的途径。”哈佛医学院附属医院。

The company's first product, Profi™, which is available to consumers today, is a revolutionary drug-free nasal spray that supports a healthy immune system, especially during periods with spikes in respiratory illnesses. Profi helps block and remove inhaled airborne contaminants for up to eight hours with one spray.

该公司的第一款产品Profi™, 今天消费者可以使用的是一种革命性的无药物鼻喷雾剂，它支持健康的免疫系统，特别是在呼吸系统疾病高峰期。Profi可以通过一次喷雾帮助阻止和清除吸入的空气污染物长达8小时。

As a new hygiene tool, Profi is as important as washing your hands to stay healthy this cold and flu season..

作为一种新的卫生工具，Profi与洗手一样重要，以保持这个寒冷和流感季节的健康。。

'Our studies identified a formulation of intranasal-safe ingredients that have excellent physical barrier properties against different respiratory pathogens,' said Dr. Nitin Joshi, Assistant Professor at Brigham and Women's Hospital and Harvard Medical School and a lead researcher for the project. 'The formulation rapidly neutralized a broad spectrum of viruses and bacteria, including Influenza A and B, SARS-CoV-2, RSV, adenovirus, E.

布莱根妇女医院和哈佛医学院助理教授，该项目的首席研究员Nitin Joshi博士说：“我们的研究确定了一种鼻内安全成分，具有优异的抗不同呼吸道病原体的物理屏障特性。”该制剂迅速中和广谱病毒和细菌，包括甲型和乙型流感，SARS-CoV-2，RSV，腺病毒，E。

coli, and K. pneumoniae; reducing the pathogen load by more than 99.99%.' Based on this research, 'Akita Biosciences developed a radically simple approach that works with the natural defenses in the nose,' said Alex Revelos, CEO.Profi is a drug-free formulation composed predominantly of ingredients that have previously been used intranasally at doses higher than in this product and which are on the FDA's Inactive Ingredient Database (IID) and Generally Recognized As Safe (GRAS) lists.

大肠杆菌和肺炎克雷伯菌；减少病原体负荷超过99.99%。“基于这项研究，Akita Biosciences开发了一种完全简单的方法，可以与鼻子中的自然防御相结合，”Alex Revelos说，CEO.Profi是一种无药物制剂，主要由先前以高于本产品剂量鼻内使用的成分组成，并且在FDA的非活性成分数据库（IID）上并且通常被认为是安全（GRAS）列表。

The spray forms a coating in the nasal cavity, which then helps traps and removes the contaminants, preventing them from moving further down the respiratory tract, while also helping maintain a hydrated environment. As a result, the natural immune function of the nose is supported.'The pandemic made us all keenly aware that the air we breathe is full of contaminants,' said Mr.

喷雾在鼻腔中形成涂层，然后有助于捕获和去除污染物，防止它们进一步向下呼吸道移动，同时还有助于维持水合环境。结果，支持了鼻子的天然免疫功能大流行让我们都敏锐地意识到我们呼吸的空气中充满了污染物，“先生说。

Revelos. 'For most of us though, it's impossible to always wear a mask and avoid social interactions. Risk is part of daily life–whether because we work in hospitals, attend conferences, teach school, or serve the hospitality industry. I'm thrilled to offer an easy-to-use option to support health and bring peace of mind this season.'The development of Profi was rooted in rigorous research and collaboration by co-founders Nitin Joshi, Ph.D, Assistant Professor at Harvard Medical School a.

启示录然而，对于我们大多数人来说，不可能总是戴口罩并避免社交互动。风险是日常生活的一部分-无论是因为我们在医院工作，参加会议，教学校还是为酒店业服务。我很高兴能够提供一个易于使用的选项来支持健康，并在本赛季带来安心。”Profi的发展植根于哈佛医学院助理教授Nitin Joshi博士的严格研究与合作。